- Home
- AQST
as 05-17-2024 4:00pm EST
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | WARREN |
| Market Cap: | 297.7M | IPO Year: | 2018 |
| Target Price: | $8.71 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.25 - $6.23 | Next Earning Date: | 05-07-2024 |
| Revenue: | $51,502,000 | Revenue Growth: | 10.65% |
| Revenue Growth (this year): | 1.26% | Revenue Growth (next year): | 15.79% |
Share on Social Networks:
Stock Insider Trading Activity of Aquestive Therapeutics Inc. (AQST)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Schobel Alexander Mark | AQST | Chief Innovation/Tech Officer | Mar 15 '24 | Sell | $6.00 | 50,000 | $300,000.00 | 984,476 | SEC Form 4 |
Latest Aquestive Therapeutics Inc. News
AQST Breaking Stock News: Dive into AQST Ticker-Specific Updates for Smart Investing
MT Newswires
9 days ago
Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target
Insider Monkey
10 days ago
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript
GlobeNewswire
10 days ago
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
Simply Wall St.
10 days ago
Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
GuruFocus.com
11 days ago
Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Zacks
12 days ago
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
Zacks
12 days ago
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
Associated Press Finance
12 days ago